Antihypertensive treatment after first stroke in primary care: Results from the General Practitioner Research Database

Journal of Hypertension

Volumn 29, Issue 1, 2011, Pages 154-160

  Toschke, André M ^a,b   Gulliford, Martin C ^b   Wolfe, Charles D A ^b,c   Rudd, Anthony G ^b,c   Heuschmann, Peter U ^b,d  

^a UNIVERSITY OF MUNICH   (Germany)

^b KING'S COLLEGE LONDON   (United Kingdom)

^c GUY'S AND ST THOMAS' NHS FOUNDATION TRUST   (United Kingdom)

^d CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

Author keywords

brain infarction; cerebrovascular disorders; hypertension; neurologic manifestations

Indexed keywords

ANGIOTENSIN 2 RECEPTOR ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; CALCIUM CHANNEL BLOCKING AGENT; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

AGED; ANTIHYPERTENSIVE THERAPY; ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PRACTICE GUIDELINE; PRESCRIPTION; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RECURRENCE RISK; RECURRENT DISEASE; SECONDARY PREVENTION; STROKE; UNITED KINGDOM;

EID: 78650810368     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/HJH.0b013e32833f3897     Document Type: Article

References (30)

1. MacMahon S, Peto R, Cutler J, Collins R, Sorlie P, Neaton J, et al. Blood pressure, stroke, and coronary heart disease. Part 1, prolonged differences in blood pressure: prospective observational studies corrected for the regression dilution bias. Lancet 1990; 335:765-774.
2. Hardie K, Jamrozik K, Hankey GJ, Broadhurst RJ, Anderson C. Trends in five-year survival and risk of recurrent stroke after first-ever stroke in the Perth Community Stroke Study. Cerebrovasc Dis 2005; 19:179-185.
3. Hillen T, Coshall C, Tilling K, Rudd AG, McGovern R, Wolfe CD. Cause of stroke recurrence is multifactorial: patterns, risk factors, and outcomes of stroke recurrence in the South London Stroke Register. Stroke 2003; 34:1457-1463.
4. Rashid P, Leonardi-Bee J, Bath P.Blood pressure reduction and secondary prevention of stroke and other vascular events: a systematic review. Stroke 2003; 34:2741-2748.
5. Zhang H, Thijs L, Staessen JA. Blood pressure lowering for primary and secondary prevention of stroke. Hypertension 2006; 48:187-195.
6. Intercollegiate Stroke Working Party. National clinical guidelines for stroke. 2nd ed. London: Royal College of Physicians; 2004.
7. Hillen T, Dundas R, Lawrence E, Stewart JA, Rudd AG, Wolfe CD. Antithrombotic and antihypertensive management 3 months after ischemic stroke: a prospective study in an inner city population. Stroke 2000; 31:469-475.
8. Bongard V, Cambou JP, Lezorovcz A, Ferreres J, Vahanan A, Jullen G, et al. Comparison of cardiovascular risk factors and drug use in 14544 French patients with a history of myocardial infarction, ischaemic stroke and/or peripheral arterial disease. Eur J Cardiovasc Prev Rehabil 2004; 11:394-402.
9. Girot M, Deplanque D, Pasquier F, Destee A, Leys D. Comparison of secondary vascular prevention in practice after cerebral ischemia and coronary heart disease. J Neurol 2004; 251:529-536.
10. Toschke AM, Wolfe CD, Heuschmann PU, Rudd AG, Gulliford M. Antihypertensive treatment after stroke and all-cause mortality: an analysis of the General Practitioner Research Database (GPRD). Cerebrovasc Dis 2009; 28:105-111.
11. Office for National Statistics (ONS). Key health statistics from general practice 1998 (Series MB6 No. 2). London: Office for National Statistics; 2000.
12. Brown MJ, Cruickshank JK, Dominiczak AF, MacGregor GA, Poulter NR, Russell GI, et al. Better blood pressure control: how to combine drugs. J Hum Hypertens 2003; 17:81-86.
13. Kurth T, Walker AM, Glynn RJ, Chan KA, Gaziano JM, Berger K, Robins JM. Results of multivariable logistic regression, propensity matching, propensity adjustment, and propensity-based weighting under conditions of nonuniform effect. Am J Epidemiol 2006; 163:262-270.
14. Heuschmann PU, Grieve AP, Toschke AM, Rudd AG, Wolfe CD. Ethnic group disparities in 10-year trends in stroke incidence and vascular risk factors: the South London Stroke Register (SLSR). Stroke 2008; 39:2204-2210.
15. Gulliford MC, Charlton J, Latinovic R. Trends in antihypertensive and lipid-lowering therapy in subjects with type II diabetes: clinical effectiveness or clinical discretion? J Hum Hypertens 2005; 19:111-117.
16. Rothwell PM, Coull AJ, Giles MF, Howard SC, Silver LE, Bull LM, et al. Change in stroke incidence, mortality, case-fatality, severity, and risk factors in Oxfordshire, UK from 1981 to 2004 (Oxford Vascular Study). Lancet 2004; 363:1925-1933.
17. Volpe M, Rosei EA, Ambrosioni E, Leonetti G, Trimarco B, Mancia G. Reduction in estimated stroke risk associated with practice-based stroke-risk assessment and awareness in a large, representative population of hypertensive patients: results from the ForLife study in Italy. J Hypertens 2007; 25:2390-2397.
18. Roland M. Linking physicians' pay to the quality of care: a major experiment in the United kingdom. N Engl J Med 2004; 351:1448-1454.
19. Paul SL, Thrift AG. Control of hypertension 5 years after stroke in the North East Melbourne Stroke Incidence Study. Hypertension 2006; 48:260-265.
20. Rudd AG, Lowe D, Hoffman A, Irwin P, Pearson M. Secondary prevention for stroke in the United Kingdom: results from the National Sentinel Audit of Stroke. Age Ageing 2004; 33:280-286.
21. De Koning JS, Klazinga N, Koudstaal PJ, Prins A, Borsboom GJ, Peeters A, Mackenbach JP. Deprivation and systematic stroke prevention in general practice: an audit among general practitioners in the Rotterdam region, The Netherlands. Eur J Public Health 2003; 13:340-346.
22. Cox AM, McKevitt C, Rudd AG, Wolfe CD. Socioeconomic status and stroke. Lancet Neurol 2006; 5:181-188.
23. Van Wijk I, Kappelle LJ, van Gijn J, Koudstaal PJ, Franke CL, Vermeulen M, et al. Long-term survival and vascular event risk after transient ischaemic attack or minor ischaemic stroke: acohort study. Lancet 2005; 365:2098-2104.
24. Hankey GJ. Long-term outcome after ischaemic stroke/transient ischaemic attack. Cerebrovasc Dis 2003; 16 (Suppl 1):14-19.
25. Walker AM, Stampfer MJ. Observational studies of drug safety. Lancet 1996; 348:489.
26. PROGRESS Collaborative Group. Randomised trial of a perindopril-based blood-pressure-lowering regimen among 6105 individuals with previous stroke or transient ischaemic attack. Lancet 2001; 358:1033-1041.
27. Gulliford MC, Charlton J, Ashworth M, Rudd AG, Toschke AM. Selection of medical diagnostic codes for analysis of electronic patient records. Application to stroke in a primary care database. PLoS One 2009; 4:e7168.
28. Sever P, Beevers G, Bulpitt C, Lever A, Ramsay L, Reid J, Swales J. Management guidelines in essential hypertension: report of the second working party of the British Hypertension Society. BMJ 1993; 306:983-987.
29. Ramsay LE, Williams B, Johnston GD, MacGregor GA, Poston L, Potter JF, et al. British Hypertension Society guidelines for hypertension management 1999: summary. BMJ 1999; 319:630-635.
30. Williams B, Poulter NR, Brown MJ, Davis M, McInnes GT, Potter JF, et al. British Hypertension Society guidelines for hypertension management 2004 (BHS-IV): summary. BMJ 2004; 328:634-640. (Pubitemid 38340037)